Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 10/20 | 0.51 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CYP11B2 | P19099 | 9/20 | 0.42 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.40 |
| ▸ | TNF | P01375 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.39 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9973772 | 0.92 | CYP2A6 (0.50) | CYP11B1GPR84CYP19A1CYP2A6KDM4E | |
| SCHEMBL28377234 | 0.86 | CYP11B1 (0.53) | CYP11B1GPR84CYP19A1CYP2A6KDM4E | |
| SCHEMBL2016269 | 0.86 | CYP2A6 (0.59) | CYP11B1GPR84CYP19A1CYP2A6ALDH1A1 | |
| SCHEMBL9973707 | 0.84 | CYP2A6 (0.57) | CYP11B1GPR84CYP19A1CYP2A6KDM4E | |
| SCHEMBL12259731 | 0.83 | CYP19A1 (0.57) | CYP11B1GPR84CYP19A1CYP2A6KDM4E | |
| SCHEMBL17320792 | 0.81 | CYP11B1 (0.50) | CYP11B1GPR84CYP19A1CYP2A6KDM4E | |
| SCHEMBL10017189 | 0.80 | CYP19A1 (0.50) | CYP11B1GPR84CYP19A1CYP2A6KDM4E | |
| SCHEMBL13820448 | 0.79 | CYP11B1 (0.59) | CYP11B1GPR84CYP19A1CYP2A6CYP11B2 | |
| SCHEMBL17320788 | 0.79 | CYP19A1 (0.47) | CYP11B1GPR84CYP19A1CYP2A6KDM4E | |
| SCHEMBL18101988 | 0.79 | CYP19A1 (0.56) | CYP11B1GPR84CYP19A1CYP2A6KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8202633-B2 | Electron transport material and organic electroluminescent device using the same | JNC CORPORATION (JP) | 2012-06-19 | — | — | US | disclosed |
| US-8202633-B2 | Electron transport material and organic electroluminescent device using the same | JNC CORPORATION (JP) | 2012-06-19 | — | — | US | disclosed |
| US-20110215310-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | SK MATERIALS JNC CO., LTD. (KR) | 2011-09-08 | — | — | US | disclosed |
| US-20110215310-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | SK MATERIALS JNC CO., LTD. (KR) | 2011-09-08 | — | — | US | disclosed |
| US-7964293-B2 | Electron transport material and organic electroluminescent device using the same | JNC CORPORATION (JP) | 2011-06-21 | — | — | US | disclosed |
| US-7964293-B2 | Electron transport material and organic electroluminescent device using the same | JNC CORPORATION (JP) | 2011-06-21 | — | — | US | disclosed |
| US-20090134780-A1 | Electron transport material and organic electroluminescent device using the same | SK MATERIALS JNC CO., LTD. (KR) | 2009-05-28 | — | — | US | disclosed |
| US-20090134780-A1 | Electron transport material and organic electroluminescent device using the same | SK MATERIALS JNC CO., LTD. (KR) | 2009-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110215310-A1 | ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | SLC25A11, ELAVL1, SLC26A3 | CYP11B1 1482/4885GPR84 1988/4885CYP19A1 3499/4885 |
| US-20090134780-A1 | Electron transport material and organic electroluminescent device using the same | SLC25A11, ELAVL1, SLC26A3 | CYP11B1 1482/4885GPR84 1988/4885CYP19A1 3499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.